Business Description
Bioptik Technology Inc
NAICS : 334510
SIC : 3845
ISIN : TW0004161005
Description
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 3.12 | |||||
| Interest Coverage | 11.12 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.94 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19 | |||||
| 3-Year Book Growth Rate | 2.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.41 | |||||
| 9-Day RSI | 30.16 | |||||
| 14-Day RSI | 32.71 | |||||
| 6-1 Month Momentum % | 6.75 | |||||
| 12-1 Month Momentum % | 11.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.35 | |||||
| Cash Ratio | 0.83 | |||||
| Days Inventory | 135.31 | |||||
| Days Sales Outstanding | 30.6 | |||||
| Days Payable | 43.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.16 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| Forward Dividend Yield % | 2.16 | |||||
| 5-Year Yield-on-Cost % | 2.17 | |||||
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 6.82 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.88 | |||||
| Operating Margin % | 11.92 | |||||
| Net Margin % | 11.28 | |||||
| FCF Margin % | 12.63 | |||||
| ROE % | 12 | |||||
| ROA % | 6.61 | |||||
| ROIC % | 8.63 | |||||
| ROC (Joel Greenblatt) % | 18.68 | |||||
| ROCE % | 12.97 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17 | |||||
| PE Ratio without NRI | 16.87 | |||||
| Shiller PE Ratio | 78.7 | |||||
| Price-to-Owner-Earnings | 14.93 | |||||
| PS Ratio | 1.93 | |||||
| PB Ratio | 2.02 | |||||
| Price-to-Tangible-Book | 1.97 | |||||
| Price-to-Free-Cash-Flow | 15.18 | |||||
| Price-to-Operating-Cash-Flow | 12.58 | |||||
| EV-to-EBIT | 14.25 | |||||
| EV-to-EBITDA | 11.13 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-FCF | 16.78 | |||||
| Price-to-Projected-FCF | 1.51 | |||||
| Price-to-Median-PS-Value | 0.7 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 7.14 | |||||
| Earnings Yield (Greenblatt) % | 7.02 | |||||
| FCF Yield % | 6.39 | |||||
| Forward Rate of Return (Yacktman) % | -28.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioptik Technology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 884.107 | ||
| EPS (TTM) (NT$) | 1.94 | ||
| Beta | 0.4 | ||
| Volatility % | 21.91 | ||
| 14-Day RSI | 32.71 | ||
| 14-Day ATR (NT$) | 0.897193 | ||
| 20-Day SMA (NT$) | 33.4075 | ||
| 12-1 Month Momentum % | 11.18 | ||
| 52-Week Range (NT$) | 27.5 - 39.55 | ||
| Shares Outstanding (Mil) | 52.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioptik Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioptik Technology Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioptik Technology Inc Frequently Asked Questions
What is Bioptik Technology Inc(ROCO:4161)'s stock price today?
The current price of ROCO:4161 is NT$32.40. The 52 week high of ROCO:4161 is NT$39.55 and 52 week low is NT$27.50.
When is next earnings date of Bioptik Technology Inc(ROCO:4161)?
The next earnings date of Bioptik Technology Inc(ROCO:4161) is .
Does Bioptik Technology Inc(ROCO:4161) pay dividends? If so, how much?
The Dividend Yield %  of Bioptik Technology Inc(ROCO:4161) is 2.16% (As of Today), Highest Dividend Payout Ratio of Bioptik Technology Inc(ROCO:4161) was 3.53. The lowest was 0.29. And the median was 1.84. The  Forward Dividend Yield % of Bioptik Technology Inc(ROCO:4161) is 2.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers